Skip to main content
. Author manuscript; available in PMC: 2019 May 19.
Published in final edited form as: Toxicol Appl Pharmacol. 2018 Aug 18;357:70–79. doi: 10.1016/j.taap.2018.08.011

Fig. 1.

Fig. 1.

Identification of sodium arsenite exposure condition. 1A and 1B showed results of Western blot of Nrf2 protein in MEF and Dot1L−/− cells after 6 h exposure. 1C showed the quantitative results of Western blot in 1A and 1B. 1D and 1E showed results of Western blot of Nrf2 protein in MEF and Dot1L−/− cells after 24 h exposure. 1F showed the quantitative results of Western blot in 1D and 1E. * P < .05.